arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Akari Therapeutics Plc

AKTX

$7.72 ▲ +0.28 (+3.76%) at close

39 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Akari Therapeutics Plc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $916.8B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -103.4% ↘

FCF / Share $-0.00

Trailing P/E —

Price / Book 49158.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

39-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-14.46M

↓ -290.1% —

FCF / Share Free cash flow per share

$-0.00

↑ +46.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Net Income Growth YoY (%)	-290.1% Weak ↓ Weak Declining Year-over-year change in net income	-40.5% Weak ↓ Weak Declining Year-over-year change in net income	33.4% Excellent ↑ Excellent Improving Year-over-year change in net income	33.4% Excellent ↑ Excellent Improving Year-over-year change in net income	33.4% Excellent Excellent Year-over-year change in net income	8.8% Fair Fair Year-over-year change in net income	N/M	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	-28.8% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-21741.9% Weak ↓ Weak Declining Year-over-year change in net income	25.0% Excellent Excellent Year-over-year change in net income	-33.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	46.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	86.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	54.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	-86.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Effective Tax Rate (%) (%)	5.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.5% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-2.45x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-4.88x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	2.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	-15.99x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Return on Invested Capital (%)	-103.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	34.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	158.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	133.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1755.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-929.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-131.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-55.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	-8.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-56.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-149.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-72.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	-22.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-46.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-107.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-146.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-216.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-116.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-29.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-54.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-100.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-770%)	-18.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-16.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-14.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-17.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-17.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	83.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+454%)	150.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+902%)	156.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+944%)	—	—	36.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+140%)	15.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—	—	—	—	—	—	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	13.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	-117.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-886%)	-171.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1245%)	-89.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-695%)	-50.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-434%)	—	-21.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	—	—	—	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Debt to Equity (x)	—	—	—	—	—	—	-0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-105%)	-0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-127%)	-0.31x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-152%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-2626.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-74.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-389.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-503.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-229.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-146.06x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	-721.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7.64x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-523.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	-75.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-2.77M	$0.00	—	$-2.71M	$-2.58M	$0.00	$-2.05M	$-3.58M	$-210.00K	$-3.85M	—	—	—	$-13.25M	$-9.36M	$-14.06M	$-6.27M	$-5.45M	$-28.11M	$-34.10M	$-61.43M	$-68.92M	$-78.77M	$-2.72M	$-4.02M	$-3.33M	$-52.61K	$-11.36M	$-13.83M	$-7.66M	$-1.10M	$-6.00K	$-9.00K	—	—	—	—	—	$0.00
Debt / EBITDA (x)	—	—	—	—	—	—	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Basic EPS, GAAP (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	—	$-0.00	$-0.00	$-0.00	—	—	—	$-0.00	—	$-0.00	$-0.00	$-0.00	—	—	—	—	—	—	—	$-0.01	—	$0.01	—	—	—	$0.05	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.00	$-0.00	$-0.00	$-0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.01	$0.03	$0.04	—	$0.04	$0.02	$0.05	—	—	—	—	$0.14	$-0.25	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.00	$-0.00	$-0.00	$-0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.01	$0.03	$0.04	—	$0.02	$0.02	$0.05	—	—	—	—	$0.14	$-0.25	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	118.76B	—	65.33B	62.94B	54.59B	—	24.39B	18.84B	13.45B	—	10.12B	10.12B	7.47B	—	—	—	—	—	—	—	1.18B	—	781.74M	—	—	—	73.37M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Working Capital (USD)	$-9.83M	$-6.89M	$-12.62M	$-13.84M	$-17.56M	$-16.96M	$-6.69M	$-3.70M	$-3.55M	$-243.00K	—	—	—	—	—	—	—	$2.54M	$16.96M	$33.92M	$46.14M	—	$41.14M	$1.96M	$3.36M	—	—	—	—	$6.60M	$-2.73M	—	—	—	—	—	—	—	—
Total Equity (USD)	$14.38M	$28.33M	$22.69M	$25.61M	$21.75M	$22.23M	$-6.69M	$-3.70M	$-3.55M	$-229.00K	$213.00K	$2.78M	$6.56M	$1.79M	$5.55M	$9.38M	$4.90M	$3.11M	$17.15M	$34.10M	$46.36M	$48.72M	$41.33M	$973.00K	$2.60M	$2.22M	—	$10.41M	—	$5.81M	$-3.36M	$-2.48M	$-2.00M	$-1.70M	$-1.26M	$-60.00K	$-467.00K	$1.23M	$0.00

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 20-F ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗	Q4 FY2018 Dec 31, 2018 20-F ↗	Q4 FY2017 Dec 31, 2017 20-F ↗	Q4 FY2016 Dec 31, 2016 20-F ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 20-F ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 20-F ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 20-F ↗	Q4 FY2011 Dec 31, 2011 10-K ↗	Q4 FY2010 Dec 31, 2010 20-F ↗	Q4 FY2009 Dec 31, 2009 20-F ↗	Q4 FY2008 Dec 31, 2008 20-F ↗	Q4 FY2007 Dec 31, 2007 20-F ↗	Q4 FY2006 Dec 31, 2006 20-F ↗	Q4 FY2005 Dec 31, 2005 20-F ↗	Q4 FY2004 Oct 6, 2004 20-F ↗
Depreciation Expense (USD)	—	—	—	—	—	$1.00K	—	—	$13.00K	$1.00K	$1.00K	$1.00K	$1.00K	—	—	—	—	—	—	—	$8.59K	$2.62K	$-4.58K	$8.24K	$5.00K	$1.60K	$1.46K	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-14.46M	$-5.30M	$-3.71M	$-3.71M	$-3.71M	$-3.77M	$-5.57M	$-5.57M	$-5.57M	$-4.14M	$1.00M	$1.00M	$1.00M	—	—	—	—	—	—	—	$-2.99M	$6.47M	$-48.74M	$-1.67M	$-2.32M	$-1.11M	$-223.13K	$-2.23M	$-1.74M	—	—	—	—	—	—	—	—	—	—
Operating Cash Flow (USD)	$-2.49M	$-3.04M	$-2.12M	$-3.26M	$-2.15M	$-2.12M	—	—	$-4.04M	$-4.41M	$-2.45M	$-4.69M	$-4.88M	—	—	—	—	—	—	—	$-7.44M	$-6.77M	$5.30M	$-1.51M	$-2.20M	—	$3.57M	$-2.33M	$-2.05M	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 22 years · 39 quarters

Akari Therapeutics Plc

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AKTX with peers